Article
Genomic insights into SARS-CoV-2 evolution in Yantai, China after the adjustment of the dynamic zero-COVID policy in 2023.
PeerJ - 1 Jan 2026
Liu Juan, Zhang Yi, Yang Liu, He Liqun, Li Xia, Zhao Lili, Hu Jingfei, Sun Yulou, Sun Zhenlu
Abstract excerpt
Coronavirus Disease 2019 (COVID-19) cases surged after China adjusted the dynamic COVID-zero strategy at the end of 2022, posing significant public health challenges in Yantai. To monitor the evolutionary process and characterize variants circulating in Yantai in 2023, 613 nasopharyngeal swab samples from confirmed COVID-19 patients were sequenced, assigned to lineages, used for phylogenetic tree construction,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
